Delivery Order SPE2DR25D7064-SPE2DR26F2NCC
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 17, 2025, for the supply of Sevoflurane Inhalation Liquid in 250ml units with a ceiling value of $1,656.66. This firm fixed-price delivery order, which must be completed by July 18, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award was made through open...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Sevoflurane Inhalation Liquid in 250ML units, valued at $1,885.44. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of October 31, 2025. The product will be performed from AmerisourceBergen's location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for Sevoflurane Inhalation Liquid in 250mL quantities, with a ceiling value of $4,649.76. This firm fixed price delivery order, issued on August 28, 2025, represents a non-competitive set-aside award and is scheduled for ultimate completion by August 29, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal...
- The Defense Logistics Agency awarded a delivery order valued at $1,378.20 to AmerisourceBergen Drug Corp for the supply of Sevoflurane Inhalation Liquid in 250ml quantities. This contract employs firm fixed price terms with an ultimate completion date of December 31, 2025, and represents a non-set-aside competitive award. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Sevoflurane Inhalation Liquid in 250ml quantities, with a ceiling value of $1,519.52. This is a firm fixed price delivery order with no set-aside designation, indicating the award was competitively procured. The order is scheduled for completion by December 9, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania facility. This delivery order is issued...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,414.08 on July 24, 2025, for the supply of Sevoflurane inhalation liquid in 250ml quantities. The contract is a firm fixed price delivery order with an ultimate completion date of July 25, 2025, and is funded by the Defense Logistics Agency's Medical Supply Chain division. This award was made through open competition with no set-aside designation,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Sevoflurane Inhalation Liquid in 250ML quantities, with a contract ceiling value of $4,563.40. Awarded on December 16, 2025, with an ultimate completion date of December 17, 2025, this firm fixed-price delivery order represents a competitively awarded procurement with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,750.38 for Sevoflurane Inhalation Liquid in 250ml quantities under a firm fixed-price contract. This award, issued on December 15, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999. The place of performance is AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $4,713.60 to AmerisourceBergen Drug Corp for the supply of Sevoflurane Inhalation Liquid in 250ml quantities. This contract, which was competitively awarded without set-aside designation, carries a firm fixed price structure with an ultimate completion date of August 29, 2025. The award was made to support federal medical procurement needs, with the place of performance located in Conshohocken, Pennsylvania, where...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on December 11, 2025, for the supply of Sevoflurane Inhalation Liquid in 250mL quantities, with a ceiling value of $1,378.50. This contract represents a firm fixed-price delivery order with an ultimate completion date of December 12, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The award was competitively awarded with no set-aside designation...
- SPE2DR25D7064Indefinite Delivery Contract
- SPE2DR25D7064-SPE2DR26F2NCCDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 30, 2025, for the supply of Sevoflurane Inhalation Liquid in 250ML units, with a ceiling value of $1,378.20. This is a firm fixed-price delivery order with an ultimate completion date of December 31, 2025, and represents a non-set-aside competitive award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's federal contract portfolio demonstrates extensive capabilities in supplying a wide range of pharmaceutical products, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This delivery order for Sevoflurane—a volatile anesthetic inhalation agent commonly used in surgical settings—exemplifies the company's role in supporting operational medical supply needs for the Department of Defense and related healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 12/29/25 |